Published 2 September 2009, doi:10.1136/bmj.b3443
Cite this as: BMJ 2009;339:b3443

Feature

Research Ethics

In clear sight

Marisa de Andrade, freelance journalist

marisa.de-andrade@strath.ac.uk

Despite measures to improve transparency of research funding, Marisa de Andrade finds there is still scope for confusion

The first 150 words of the full text of this article appear below.

On a Friday night in March 2009, I joined more than 30 doctors gathered at the Gleneagles Hotel for predinner drinks. We were attending a weekend meeting at the invitation of the University of Dundee’s Hypertension Research Centre and Medicines Monitoring Unit after "positive feedback" from a similar gathering in January. Both meetings aimed to provide practices with sufficient information about the Standard Care versus Celecoxib Outcome Trial (SCOT) to enable general practitioners to decide whether to participate.

The invitation did not mention Pfizer, although the drug company was providing £26m ({euro}30m; $43m) for the study.1 Instead, the trial was described as "an academic, investigator-initiated study, requested by the European Medicines Agency (EMEA) and sponsored by the University of Dundee." The university is working in partnership with the universities of Glasgow, Edinburgh, and Aberdeen and collaborating with researchers from Nottingham University and the University of Southern Denmark.2 3

The SCOT . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Article

Tom MacDonald replies to Marisa de Andrade
Tom MacDonald
BMJ 2009 339: b4281. [Extract] [Full Text]

This article has been cited by other articles:

  • MacDonald, T. (2009). Tom MacDonald replies to Marisa de Andrade. BMJ 339: b4281-b4281 [Full text]  

Rapid Responses:

Read all Rapid Responses

What story?
Dan Rutherford
bmj.com, 10 Sep 2009 [Full text]
In Clear Sight Response
Christopher J Hawkey, et al.
bmj.com, 17 Sep 2009 [Full text]
Re: In Clear Sight Response
Keith Baxby
bmj.com, 22 Sep 2009 [Full text]
The SCOT Trial; a clearer perspective
Tom M MacDonald
bmj.com, 9 Oct 2009 [Full text]



Access jobs at BMJ Careers
Whats new online at Student 

BMJ